Generics 11

Innovative

Biosimilars

Medical devices

Nutraceuticals

Filters

Fludrocortisone manufacturers

11 products found

Filters

11 products found

fludrocortisone

Tablets 100 mcg

Dossier type
EU CTD
Dossier status
Ready to file
Country of origin
European Union
GMP approvals
EU GMP
Manufacturer #38366

Manufacturer founded in 2014 in Düsseldorf, Germany operates as a CTD dossier owner and manufacturer. It is also a GMP manufacturer under EU and international GMP standards. Its headcount is around 501–1,000 employees. Products are sold worldwide: in EU & non-EU Europe, East Asia (including China), South East Asia, Middle East, Africa, Americas. As a CTD dossier owner and manufacturer, it holds approvals such as China’s NMPA + EU registrations. Being a GMP manufacturer, production lines include finished dosage forms (e.g. oral sprays), managed under certified cleanroom environments, quality assurance, regulatory affairs. Manufacturer acts as CTD dossier owner and manufacturer, integrating R&D, registration, commercialisation

Manufacturer usually replies in 11 days

Differentiated product

fludrocortisone

Oral solution 0.1 mg/ml - 50 ml

Dossier type
EU CTD
Dossier status
Ready to file
Country of origin
European Union
GMP approvals
EU GMP
Unavailable markets
France , Germany , Greece , Luxembourg , Netherlands , United Kingdom
Registered in
France , United Kingdom
Manufacturer #15507

A privately owned CDMA service provider that is aimed to benefit people from its pharmaceutical solutions. They have dosages in the form of oral liquid and likewise. The company is one of the pioneers of having high-value credentials in the development, manufacturing, and commercialization of healthcare products.

Manufacturer usually replies in 28 days

fludrocortisone

Tablets 0.1 mg

Dossier type
EU CTD
Dossier status
Ready to file
Country of origin
European Union
GMP approvals
EU GMP
Unavailable markets
United Kingdom , Vietnam
Manufacturer #358
A pharmaceutical manufacturer based in the EU that is active in 70+ countries worldwide selling its products in the EU, Australia, Pacific region, and Asia for 30+ years. The company owns several manufacturing plants that comply with EU GMP requirements with production facilities for Rx products, OTC products, nutraceuticals, and medical devices. Its key therapy areas are diabetology, oncology, and neuropsychiatry. The company possesses several R&D centers with hundreds of patents and provides e-CTD format dossiers.

Manufacturer usually replies in 31 days

Want to see all 11 products?

Subscribe today to benefit from:

  • Streamlined product sourcing - the leading CTD dossiers database focused on finished dosage formulations

  • Direct negotiations - connect and negotiate directly with manufacturers without any brokerage fee

  • Increased profitability - secure the best commercial terms for your business by comparing offers from several manufacturers

Request Subscription
Fludrocortisone is a steroid class drug that is used to treat adrenogenital syndrome, adrenal insufficiency, Addison's disease, dysautonomia, and postural hypotension. Suppliers market it in the form of 0.1mg fludrocortisone tablets. In use since 1953, the drug is now listed by the WHO as one of the safest and most effective drugs needed for a basic health system. In contrast to its acetate ester form - fludrocortisone acetate – it is only available in a limited number of European countries. Major manufacturers and suppliers of fludrocortisone medications include Bristol-Meyers Squibb and Merck. Fludrocortisone is available in both generic and trade name formulations. Buyers are advised that online sellers may attempt to market fraudulent versions of the generic drug, whereas Pipeline Pharma, through its pre-auditing and quality control procedures ensures that only verified manufacturers and wholesalers enter our online marketplace, offering you a risk-free B2B pharmaceutical sales platform. Retail prices of fludrocortisone vary depending on supplier and manufacturer pricing. 20 100mcg fludrocortisone tablets can cost from 3.00 EUR to 5.00 EUR.

Interested in Subscription?

Please fill out form and send us your specific requirements, and we will get back to you as soon as possible

Want unlimited access to the Pipelinepharma database?

Become a subscriber to unlock:

  • Streamlined product sourcing: access the only CTD dossier pipeline and sourcing platform.

  • Direct connections: communicate directly with CTD dossier owners and manufacturers with no brokerage fees.

  • Higher profitability: compare multiple supplier offers and secure the best commercial terms.

  • Expanded network: view supplier portfolios and stay updated on new products.

  • Value-added product ideas: discover products with lower competition potential.

  • Access to marketing authorizations for sale: find already registered products in your target markets.